These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3021610)

  • 1. Endogenous protein inhibitor of mitochondrial c-AMP phosphodiesterase in tumour bearing rats.
    Sankaran K
    Indian J Biochem Biophys; 1986 Apr; 23(2):66-9. PubMed ID: 3021610
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver.
    Hoshi Y
    Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by the insecticide DDT.
    Hagmann J
    FEBS Lett; 1982 Jun; 143(1):52-4. PubMed ID: 6288452
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adenosine cyclic-3',5'-monophosphate phosphodiesterase in hepatomas with different growth rates].
    Pavlova VM; Bogdanov GN; Vatolkina OE; Libinzon RE
    Eksp Onkol; 1984; 6(4):28-30. PubMed ID: 6094146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Aza-anthraquinones as inhibitors of the Ca(2+)- and calmodulin-dependent cyclic adenosine 3',5'-monophosphate phosphodiesterase.
    Gräfe U; Römer W
    Pharmazie; 1991 Apr; 46(4):297-8. PubMed ID: 1653425
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterase activity of Medicago sativa L.
    Robinson PS; Cooke CJ; Newton RP; Walton TJ; Smith CJ
    Biochem Soc Trans; 1992 Nov; 20(4):355S. PubMed ID: 1336739
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of amoscanate with the cyclic AMP-phosphodiesterases from Schistosoma mansoni, Onchocerca volvulus and bovine heart.
    Walter RD; Albiez EJ
    Tropenmed Parasitol; 1984 Jun; 35(2):78-80. PubMed ID: 6087521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of rat parotid low Km cyclic AMP phosphodiesterase by isoproterenol.
    Teo TS; Lee MK; Thiyagarajah P
    Biochem Int; 1987 Feb; 14(2):327-36. PubMed ID: 3034281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory action of cyclandelate and a number of its metabolites on cyclic AMP phosphodiesterase.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():20-5. PubMed ID: 6331483
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review.
    Sharma RK; Das SB; Lakshmikuttyamma A; Selvakumar P; Shrivastav A
    Int J Mol Med; 2006 Jul; 18(1):95-105. PubMed ID: 16786160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interaction between cAMP and calcium in calmodulin-dependent cyclic nucleotide phosphodiesterase system.
    Sharma RK; Kalra J
    Clin Invest Med; 1994 Aug; 17(4):374-82. PubMed ID: 7982300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of taurine on myocardial metabolism: role of calmodulin.
    Schaffer SW; Kramer JH; Lampson WG; Kulakowski E; Sakane Y
    Prog Clin Biol Res; 1983; 125():39-50. PubMed ID: 6308681
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 17. New substituted triaza-benzo[cd]azulen-9-ones as promising phosphodiesterase-4 inhibitors.
    Devillers I; Pevet I; Jacobelli H; Durand C; Fasquelle V; Puaud J; Gaudillière B; Idrissi M; Moreau F; Wrigglesworth R
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3303-6. PubMed ID: 15149695
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
    Birk S; Edvinsson L; Olesen J; Kruuse C
    Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin sensitive phosphodiesterase of porcine cerebral cortex: kinetic behavior, calmodulin activation, and stability.
    Keravis TM; Duemler BH; Wells JN
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):365-72. PubMed ID: 3040819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP phosphodiesterase (PDE) in microtubule preparations. I. The influence of calmodulin and Ca2+ on the PDE activity.
    Künkel W; Römer W
    Acta Histochem Suppl; 1983; 27():303-9. PubMed ID: 6306726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.